Phathom Pharmaceuticals (PHAT) Debt Ratio (2019 - 2026)

Phathom Pharmaceuticals (PHAT) has 8 years of Debt Ratio data on file, last reported at 0.54 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.54, down 22.35% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.54 (down 22.35% YoY), and the FY2025 annual result was 0.81, up 51.55% from the prior year.
• Debt Ratio slipped to 0.54 in Q1 2026 per PHAT's latest filing, from 0.81 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.86 in Q3 2025 and troughed at 0.33 in Q4 2023.
• A 5-year average of 0.56 and a median of 0.54 in 2026 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2023: Debt Ratio soared 217.78% in 2022, then plunged 42.38% in 2023.
• A 5-year view of Debt Ratio shows it stood at 0.58 in 2022, then sank by 42.38% to 0.33 in 2023, then soared by 59.84% to 0.53 in 2024, then soared by 51.55% to 0.81 in 2025, then plunged by 33.51% to 0.54 in 2026.
• Business Quant data shows PHAT's Debt Ratio at 0.54 in Q1 2026, 0.81 in Q4 2025, and 0.86 in Q3 2025.